Literature DB >> 26974484

Effect of Korean Red Ginseng on Cognitive Function and Quantitative EEG in Patients with Alzheimer's Disease: A Preliminary Study.

Jae-Hyeok Heo1, Min-Ho Park1, Jeong-Heon Lee1.   

Abstract

BACKGROUND: Korean red ginseng (KRG) has a nootropic effect. This study assessed the efficacy of KRG on cognitive function and quantitative electroencephalography (EEG) in patients with Alzheimer's disease (AD).
METHODS: Fourteen patients with AD (mean age, 74.93 years; 11 women and 3 men) were recruited and treated with KRG (4.5 g per day) for 12 weeks. Cognitive function was assessed by the Korean Mini-Mental State Examination (K-MMSE) and the Frontal Assessment Battery (FAB). EEG performed before and after treatment were analyzed with quantitative spectral analysis.
RESULTS: The FAB score improved significantly after 12 weeks of treatment. In the relative power spectrum analysis performed according to responsiveness, alpha power increased significantly in the right temporal area of the responders. The increments of relative alpha power in the right temporal, parietal, and occipital areas were significantly higher in the responders than the nonresponders.
CONCLUSIONS: This study indicates the efficacy of KRG on frontal lobe function in AD, related to increasing relative alpha power.

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 26974484     DOI: 10.1089/acm.2015.0265

Source DB:  PubMed          Journal:  J Altern Complement Med        ISSN: 1075-5535            Impact factor:   2.579


  8 in total

Review 1.  Bioactive Compounds and Their Derivatives: An Insight into Prospective Phytotherapeutic Approach against Alzheimer's Disease.

Authors:  Fahadul Islam; Jannatul Fardous Khadija; Md Harun-Or-Rashid; Md Saidur Rahaman; Mohamed H Nafady; Md Rezaul Islam; Aklima Akter; Talha Bin Emran; Polrat Wilairatana; Mohammad S Mubarak
Journal:  Oxid Med Cell Longev       Date:  2022-04-11       Impact factor: 7.310

2.  Korean Red Ginseng saponin fraction exerts anti-inflammatory effects by targeting the NF-κB and AP-1 pathways.

Authors:  Jeong-Oog Lee; Yanyan Yang; Yu Tao; Young-Su Yi; Jae Youl Cho
Journal:  J Ginseng Res       Date:  2022-02-24       Impact factor: 5.735

Review 3.  A Systematic Review of Intervention Studies Examining Nutritional and Herbal Therapies for Mild Cognitive Impairment and Dementia Using Neuroimaging Methods: Study Characteristics and Intervention Efficacy.

Authors:  Genevieve Z Steiner; Danielle C Mathersul; Freya MacMillan; David A Camfield; Nerida L Klupp; Sai W Seto; Yong Huang; Mark I Hohenberg; Dennis H Chang
Journal:  Evid Based Complement Alternat Med       Date:  2017-02-19       Impact factor: 2.629

4.  Red Ginseng Inhibits Tau Aggregation and Promotes Tau Dissociation In Vitro.

Authors:  Soo Jung Shin; Yong Ho Park; Seong Gak Jeon; Sujin Kim; Yunkwon Nam; Sang-Muk Oh; Yong Yook Lee; Minho Moon
Journal:  Oxid Med Cell Longev       Date:  2020-06-30       Impact factor: 6.543

Review 5.  Panax ginseng components and the pathogenesis of Alzheimer's disease (Review).

Authors:  Mayya Petrovna Razgonova; Valery Vyacheslavovich Veselov; Alexander Mikhailovich Zakharenko; Kirill Sergeyevich Golokhvast; Alexander Evgenyevich Nosyrev; Giancarlo Cravotto; Aristidis Tsatsakis; Demetrios A Spandidos
Journal:  Mol Med Rep       Date:  2019-02-19       Impact factor: 2.952

Review 6.  Neuroprotective Natural Products for Alzheimer's Disease.

Authors:  Xin Chen; Joshua Drew; Wren Berney; Wei Lei
Journal:  Cells       Date:  2021-05-25       Impact factor: 6.600

Review 7.  Panax ginseng as an adjuvant treatment for Alzheimer's disease.

Authors:  Hyeon-Joong Kim; Seok-Won Jung; Seog-Young Kim; Ik-Hyun Cho; Hyoung-Chun Kim; Hyewhon Rhim; Manho Kim; Seung-Yeol Nah
Journal:  J Ginseng Res       Date:  2018-01-12       Impact factor: 6.060

8.  Korean Red Ginseng Enhances Neurogenesis in the Subventricular Zone of 1-Methyl-4-Phenyl-1,2,3,6-Tetrahydropyridine-Treated Mice.

Authors:  Sun Ryu; Hyongjun Jeon; Sungtae Koo; Seungtae Kim
Journal:  Front Aging Neurosci       Date:  2018-11-06       Impact factor: 5.750

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.